BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karatoprak GŞ, Küpeli Akkol E, Genç Y, Bardakci H, Yücel Ç, Sobarzo-Sánchez E. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications. Molecules 2020;25:E2560. [PMID: 32486408 DOI: 10.3390/molecules25112560] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Banwo K, Olojede AO, Adesulu-dahunsi AT, Verma DK, Thakur M, Tripathy S, Singh S, Patel AR, Gupta AK, Aguilar CN, Utama GL. Functional importance of bioactive compounds of foods with Potential Health Benefits: A review on recent trends. Food Bioscience 2021;43:101320. [DOI: 10.1016/j.fbio.2021.101320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sekar P, Ravitchandirane R, Khanam S, Muniraj N, Cassinadane AV. Novel molecules as the emerging trends in cancer treatment: an update. Med Oncol 2022;39:20. [PMID: 34982273 DOI: 10.1007/s12032-021-01615-6] [Reference Citation Analysis]
3 Kostin RK, Marshavin AS. Pyrazoles, isoxazoles, and 1,2,3-triazoles as analogs of the natural cytostatic combretastatin A-4: efficient routes of synthesis, tubulin inhibition, and cytotoxicity. Chem Heterocycl Comp 2021;57:1061-72. [DOI: 10.1007/s10593-021-03025-y] [Reference Citation Analysis]
4 Garcia-Oliveira P, Otero P, Pereira AG, Chamorro F, Carpena M, Echave J, Fraga-Corral M, Simal-Gandara J, Prieto MA. Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment. Pharmaceuticals (Basel) 2021;14:157. [PMID: 33673021 DOI: 10.3390/ph14020157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Cai A, Yan W, Zeng X, Zacate SB, Chao TH, Krause JA, Cheng MJ, Liu W. Copper-catalyzed carbo-difluoromethylation of alkenes via radical relay. Nat Commun 2021;12:3272. [PMID: 34075051 DOI: 10.1038/s41467-021-23590-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? J Med Chem 2021;64:11364-78. [PMID: 34342437 DOI: 10.1021/acs.jmedchem.1c00706] [Reference Citation Analysis]
7 Al-Bari MAA, Ito Y, Ahmed S, Radwan N, Ahmed HS, Eid N. Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer. Int J Mol Sci 2021;22:9807. [PMID: 34575981 DOI: 10.3390/ijms22189807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Eissa IH, Dahab MA, Ibrahim MK, Alsaif NA, Alanazi AZ, Eissa SI, Mehany ABM, Beauchemin AM. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg Chem 2021;112:104965. [PMID: 34020238 DOI: 10.1016/j.bioorg.2021.104965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu L, O'Kelly D, Schuetze R, Carlson G, Zhou H, Trawick ML, Pinney KG, Mason RP. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. Molecules 2021;26:2551. [PMID: 33925707 DOI: 10.3390/molecules26092551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Malebari AM, Wang S, Greene TF, O'Boyle NM, Fayne D, Khan MF, Nathwani SM, Twamley B, McCabe T, Zisterer DM, Meegan MJ. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals (Basel) 2021;14:1119. [PMID: 34832901 DOI: 10.3390/ph14111119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Treekoon J, Pewklang T, Chansaenpak K, Gorantla JN, Pengthaisong S, Lai RY, Ketudat-Cairns JR, Kamkaew A. Glucose conjugated aza-BODIPY for enhanced photodynamic cancer therapy. Org Biomol Chem 2021;19:5867-75. [PMID: 34124730 DOI: 10.1039/d1ob00400j] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zaki I, Abou-Elkhair RAI, Abu Almaaty AH, A Abu Ali O, Fayad E, Ahmed Gaafar AG, Zakaria MY. Design and Synthesis of Newly Synthesized Acrylamide Derivatives as Potential Chemotherapeutic Agents against MCF-7 Breast Cancer Cell Line Lodged on PEGylated Bilosomal Nano-Vesicles for Improving Cytotoxic Activity. Pharmaceuticals (Basel) 2021;14:1021. [PMID: 34681245 DOI: 10.3390/ph14101021] [Reference Citation Analysis]
13 Kowalczyk P, Trzepizur D, Szymczak M, Skiba G, Kramkowski K, Ostaszewski R. 1,2-Diarylethanols-A New Class of Compounds That Are Toxic to E. coli K12, R2-R4 Strains. Materials (Basel) 2021;14:1025. [PMID: 33671509 DOI: 10.3390/ma14041025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu X, Pang XJ, Liu Y, Liu WB, Li YR, Yu GX, Zhang YB, Song J, Zhang SY. Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity. Molecules 2021;26:4047. [PMID: 34279387 DOI: 10.3390/molecules26134047] [Reference Citation Analysis]